INCENP and cancer: Our current study clearly revealed that PRMT1-mediated INCENP methylation is a critical event for activation of AURKB, and attenuation of this methylation led to repression of the AURKB enzyme activity in cancer cells, implying that inhibition of INCENP methylation by PRMT1 appears to be a good approach to develop anti-cancer drugs.